Democrats investigate MFN deals with letters to drugmakers

Democrats have sent a new round of letters to 27 drug companies seeking unredacted contracts and details of their most-favored-nation pricing agreements with the Trump administration. The incoming chairs of key House and Senate committees are preparing to make the deals a major oversight priority when Democrats take the majority in January. The requests follow earlier inquiries into agreements linking Medicaid drug prices to those in peer countries.